✉  info@marketresearchfuture.com   📞 +1 (855) 661-4441(US)   📞 +44 1720 412 167(UK)   📞 +91 2269738890(APAC)
Certified Global Research Member
Isomar 1 Iso 1
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

GLP-1 Drug Market Research Report By Drug Type (Short-acting, Long-acting, Dual-action), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Indication (Type 2 Diabetes, Obesity, Cardiovascular Diseases), By Administration Route (Subcutaneous Injection, Oral, Inhalation) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa)- Forecast to 2035


ID: MRFR/HC/20411-HCR | 128 Pages | Author: Rahul Gotadki| April 2025

GLP-1 Drug Market Segmentation




  • GLP-1 Drug Market By Drug Type (USD Billion, 2019-2035)




    • Short-acting




    • Long-acting




    • Dual-action








  • GLP-1 Drug Market By Distribution Channel (USD Billion, 2019-2035)




    • Hospital Pharmacies




    • Retail Pharmacies




    • Online Pharmacies








  • GLP-1 Drug Market By Indication (USD Billion, 2019-2035)




    • Type 2 Diabetes




    • Obesity




    • Cardiovascular Diseases








  • GLP-1 Drug Market By Administration Route (USD Billion, 2019-2035)




    • Subcutaneous Injection




    • Oral




    • Inhalation








  • GLP-1 Drug Market By Regional (USD Billion, 2019-2035)




    • North America




    • Europe




    • South America




    • Asia Pacific




    • Middle East and Africa






GLP-1 Drug Market Regional Outlook (USD Billion, 2019-2035)




  • North America Outlook (USD Billion, 2019-2035)




    • North America GLP-1 Drug Market by Drug Type




      • Short-acting




      • Long-acting




      • Dual-action






    • North America GLP-1 Drug Market by Distribution Channel Type




      • Hospital Pharmacies




      • Retail Pharmacies




      • Online Pharmacies






    • North America GLP-1 Drug Market by Indication Type




      • Type 2 Diabetes




      • Obesity




      • Cardiovascular Diseases






    • North America GLP-1 Drug Market by Administration Route Type




      • Subcutaneous Injection




      • Oral




      • Inhalation






    • North America GLP-1 Drug Market by Regional Type




      • US




      • Canada






    • US Outlook (USD Billion, 2019-2035)




    • US GLP-1 Drug Market by Drug Type




      • Short-acting




      • Long-acting




      • Dual-action






    • US GLP-1 Drug Market by Distribution Channel Type




      • Hospital Pharmacies




      • Retail Pharmacies




      • Online Pharmacies






    • US GLP-1 Drug Market by Indication Type




      • Type 2 Diabetes




      • Obesity




      • Cardiovascular Diseases






    • US GLP-1 Drug Market by Administration Route Type




      • Subcutaneous Injection




      • Oral




      • Inhalation






    • CANADA Outlook (USD Billion, 2019-2035)




    • CANADA GLP-1 Drug Market by Drug Type




      • Short-acting




      • Long-acting




      • Dual-action






    • CANADA GLP-1 Drug Market by Distribution Channel Type




      • Hospital Pharmacies




      • Retail Pharmacies




      • Online Pharmacies






    • CANADA GLP-1 Drug Market by Indication Type




      • Type 2 Diabetes




      • Obesity




      • Cardiovascular Diseases






    • CANADA GLP-1 Drug Market by Administration Route Type




      • Subcutaneous Injection




      • Oral




      • Inhalation








  • Europe Outlook (USD Billion, 2019-2035)




    • Europe GLP-1 Drug Market by Drug Type




      • Short-acting




      • Long-acting




      • Dual-action






    • Europe GLP-1 Drug Market by Distribution Channel Type




      • Hospital Pharmacies




      • Retail Pharmacies




      • Online Pharmacies






    • Europe GLP-1 Drug Market by Indication Type




      • Type 2 Diabetes




      • Obesity




      • Cardiovascular Diseases






    • Europe GLP-1 Drug Market by Administration Route Type




      • Subcutaneous Injection




      • Oral




      • Inhalation






    • Europe GLP-1 Drug Market by Regional Type




      • Germany




      • UK




      • France




      • Russia




      • Italy




      • Spain




      • Rest of Europe






    • GERMANY Outlook (USD Billion, 2019-2035)




    • GERMANY GLP-1 Drug Market by Drug Type




      • Short-acting




      • Long-acting




      • Dual-action






    • GERMANY GLP-1 Drug Market by Distribution Channel Type




      • Hospital Pharmacies




      • Retail Pharmacies




      • Online Pharmacies






    • GERMANY GLP-1 Drug Market by Indication Type




      • Type 2 Diabetes




      • Obesity




      • Cardiovascular Diseases






    • GERMANY GLP-1 Drug Market by Administration Route Type




      • Subcutaneous Injection




      • Oral




      • Inhalation






    • UK Outlook (USD Billion, 2019-2035)




    • UK GLP-1 Drug Market by Drug Type




      • Short-acting




      • Long-acting




      • Dual-action






    • UK GLP-1 Drug Market by Distribution Channel Type




      • Hospital Pharmacies




      • Retail Pharmacies




      • Online Pharmacies






    • UK GLP-1 Drug Market by Indication Type




      • Type 2 Diabetes




      • Obesity




      • Cardiovascular Diseases






    • UK GLP-1 Drug Market by Administration Route Type




      • Subcutaneous Injection




      • Oral




      • Inhalation






    • FRANCE Outlook (USD Billion, 2019-2035)




    • FRANCE GLP-1 Drug Market by Drug Type




      • Short-acting




      • Long-acting




      • Dual-action






    • FRANCE GLP-1 Drug Market by Distribution Channel Type




      • Hospital Pharmacies




      • Retail Pharmacies




      • Online Pharmacies






    • FRANCE GLP-1 Drug Market by Indication Type




      • Type 2 Diabetes




      • Obesity




      • Cardiovascular Diseases






    • FRANCE GLP-1 Drug Market by Administration Route Type




      • Subcutaneous Injection




      • Oral




      • Inhalation






    • RUSSIA Outlook (USD Billion, 2019-2035)




    • RUSSIA GLP-1 Drug Market by Drug Type




      • Short-acting




      • Long-acting




      • Dual-action






    • RUSSIA GLP-1 Drug Market by Distribution Channel Type




      • Hospital Pharmacies




      • Retail Pharmacies




      • Online Pharmacies






    • RUSSIA GLP-1 Drug Market by Indication Type




      • Type 2 Diabetes




      • Obesity




      • Cardiovascular Diseases






    • RUSSIA GLP-1 Drug Market by Administration Route Type




      • Subcutaneous Injection




      • Oral




      • Inhalation






    • ITALY Outlook (USD Billion, 2019-2035)




    • ITALY GLP-1 Drug Market by Drug Type




      • Short-acting




      • Long-acting




      • Dual-action






    • ITALY GLP-1 Drug Market by Distribution Channel Type




      • Hospital Pharmacies




      • Retail Pharmacies




      • Online Pharmacies






    • ITALY GLP-1 Drug Market by Indication Type




      • Type 2 Diabetes




      • Obesity




      • Cardiovascular Diseases






    • ITALY GLP-1 Drug Market by Administration Route Type




      • Subcutaneous Injection




      • Oral




      • Inhalation






    • SPAIN Outlook (USD Billion, 2019-2035)




    • SPAIN GLP-1 Drug Market by Drug Type




      • Short-acting




      • Long-acting




      • Dual-action






    • SPAIN GLP-1 Drug Market by Distribution Channel Type




      • Hospital Pharmacies




      • Retail Pharmacies




      • Online Pharmacies






    • SPAIN GLP-1 Drug Market by Indication Type




      • Type 2 Diabetes




      • Obesity




      • Cardiovascular Diseases






    • SPAIN GLP-1 Drug Market by Administration Route Type




      • Subcutaneous Injection




      • Oral




      • Inhalation






    • REST OF EUROPE Outlook (USD Billion, 2019-2035)




    • REST OF EUROPE GLP-1 Drug Market by Drug Type




      • Short-acting




      • Long-acting




      • Dual-action






    • REST OF EUROPE GLP-1 Drug Market by Distribution Channel Type




      • Hospital Pharmacies




      • Retail Pharmacies




      • Online Pharmacies






    • REST OF EUROPE GLP-1 Drug Market by Indication Type




      • Type 2 Diabetes




      • Obesity




      • Cardiovascular Diseases






    • REST OF EUROPE GLP-1 Drug Market by Administration Route Type




      • Subcutaneous Injection




      • Oral




      • Inhalation








  • APAC Outlook (USD Billion, 2019-2035)




    • APAC GLP-1 Drug Market by Drug Type




      • Short-acting




      • Long-acting




      • Dual-action






    • APAC GLP-1 Drug Market by Distribution Channel Type




      • Hospital Pharmacies




      • Retail Pharmacies




      • Online Pharmacies






    • APAC GLP-1 Drug Market by Indication Type




      • Type 2 Diabetes




      • Obesity




      • Cardiovascular Diseases






    • APAC GLP-1 Drug Market by Administration Route Type




      • Subcutaneous Injection




      • Oral




      • Inhalation






    • APAC GLP-1 Drug Market by Regional Type




      • China




      • India




      • Japan




      • South Korea




      • Malaysia




      • Thailand




      • Indonesia




      • Rest of APAC






    • CHINA Outlook (USD Billion, 2019-2035)




    • CHINA GLP-1 Drug Market by Drug Type




      • Short-acting




      • Long-acting




      • Dual-action






    • CHINA GLP-1 Drug Market by Distribution Channel Type




      • Hospital Pharmacies




      • Retail Pharmacies




      • Online Pharmacies






    • CHINA GLP-1 Drug Market by Indication Type




      • Type 2 Diabetes




      • Obesity




      • Cardiovascular Diseases






    • CHINA GLP-1 Drug Market by Administration Route Type




      • Subcutaneous Injection




      • Oral




      • Inhalation






    • INDIA Outlook (USD Billion, 2019-2035)




    • INDIA GLP-1 Drug Market by Drug Type




      • Short-acting




      • Long-acting




      • Dual-action






    • INDIA GLP-1 Drug Market by Distribution Channel Type




      • Hospital Pharmacies




      • Retail Pharmacies




      • Online Pharmacies






    • INDIA GLP-1 Drug Market by Indication Type




      • Type 2 Diabetes




      • Obesity




      • Cardiovascular Diseases






    • INDIA GLP-1 Drug Market by Administration Route Type




      • Subcutaneous Injection




      • Oral




      • Inhalation






    • JAPAN Outlook (USD Billion, 2019-2035)




    • JAPAN GLP-1 Drug Market by Drug Type




      • Short-acting




      • Long-acting




      • Dual-action






    • JAPAN GLP-1 Drug Market by Distribution Channel Type




      • Hospital Pharmacies




      • Retail Pharmacies




      • Online Pharmacies






    • JAPAN GLP-1 Drug Market by Indication Type




      • Type 2 Diabetes




      • Obesity




      • Cardiovascular Diseases






    • JAPAN GLP-1 Drug Market by Administration Route Type




      • Subcutaneous Injection




      • Oral




      • Inhalation






    • SOUTH KOREA Outlook (USD Billion, 2019-2035)




    • SOUTH KOREA GLP-1 Drug Market by Drug Type




      • Short-acting




      • Long-acting




      • Dual-action






    • SOUTH KOREA GLP-1 Drug Market by Distribution Channel Type




      • Hospital Pharmacies




      • Retail Pharmacies




      • Online Pharmacies






    • SOUTH KOREA GLP-1 Drug Market by Indication Type




      • Type 2 Diabetes




      • Obesity




      • Cardiovascular Diseases






    • SOUTH KOREA GLP-1 Drug Market by Administration Route Type




      • Subcutaneous Injection




      • Oral




      • Inhalation






    • MALAYSIA Outlook (USD Billion, 2019-2035)




    • MALAYSIA GLP-1 Drug Market by Drug Type




      • Short-acting




      • Long-acting




      • Dual-action






    • MALAYSIA GLP-1 Drug Market by Distribution Channel Type




      • Hospital Pharmacies




      • Retail Pharmacies




      • Online Pharmacies






    • MALAYSIA GLP-1 Drug Market by Indication Type




      • Type 2 Diabetes




      • Obesity




      • Cardiovascular Diseases






    • MALAYSIA GLP-1 Drug Market by Administration Route Type




      • Subcutaneous Injection




      • Oral




      • Inhalation






    • THAILAND Outlook (USD Billion, 2019-2035)




    • THAILAND GLP-1 Drug Market by Drug Type




      • Short-acting




      • Long-acting




      • Dual-action






    • THAILAND GLP-1 Drug Market by Distribution Channel Type




      • Hospital Pharmacies




      • Retail Pharmacies




      • Online Pharmacies






    • THAILAND GLP-1 Drug Market by Indication Type




      • Type 2 Diabetes




      • Obesity




      • Cardiovascular Diseases






    • THAILAND GLP-1 Drug Market by Administration Route Type




      • Subcutaneous Injection




      • Oral




      • Inhalation






    • INDONESIA Outlook (USD Billion, 2019-2035)




    • INDONESIA GLP-1 Drug Market by Drug Type




      • Short-acting




      • Long-acting




      • Dual-action






    • INDONESIA GLP-1 Drug Market by Distribution Channel Type




      • Hospital Pharmacies




      • Retail Pharmacies




      • Online Pharmacies






    • INDONESIA GLP-1 Drug Market by Indication Type




      • Type 2 Diabetes




      • Obesity




      • Cardiovascular Diseases






    • INDONESIA GLP-1 Drug Market by Administration Route Type




      • Subcutaneous Injection




      • Oral




      • Inhalation






    • REST OF APAC Outlook (USD Billion, 2019-2035)




    • REST OF APAC GLP-1 Drug Market by Drug Type




      • Short-acting




      • Long-acting




      • Dual-action






    • REST OF APAC GLP-1 Drug Market by Distribution Channel Type




      • Hospital Pharmacies




      • Retail Pharmacies




      • Online Pharmacies






    • REST OF APAC GLP-1 Drug Market by Indication Type




      • Type 2 Diabetes




      • Obesity




      • Cardiovascular Diseases






    • REST OF APAC GLP-1 Drug Market by Administration Route Type




      • Subcutaneous Injection




      • Oral




      • Inhalation








  • South America Outlook (USD Billion, 2019-2035)




    • South America GLP-1 Drug Market by Drug Type




      • Short-acting




      • Long-acting




      • Dual-action






    • South America GLP-1 Drug Market by Distribution Channel Type




      • Hospital Pharmacies




      • Retail Pharmacies




      • Online Pharmacies






    • South America GLP-1 Drug Market by Indication Type




      • Type 2 Diabetes




      • Obesity




      • Cardiovascular Diseases






    • South America GLP-1 Drug Market by Administration Route Type




      • Subcutaneous Injection




      • Oral




      • Inhalation






    • South America GLP-1 Drug Market by Regional Type




      • Brazil




      • Mexico




      • Argentina




      • Rest of South America






    • BRAZIL Outlook (USD Billion, 2019-2035)




    • BRAZIL GLP-1 Drug Market by Drug Type




      • Short-acting




      • Long-acting




      • Dual-action






    • BRAZIL GLP-1 Drug Market by Distribution Channel Type




      • Hospital Pharmacies




      • Retail Pharmacies




      • Online Pharmacies






    • BRAZIL GLP-1 Drug Market by Indication Type




      • Type 2 Diabetes




      • Obesity




      • Cardiovascular Diseases






    • BRAZIL GLP-1 Drug Market by Administration Route Type




      • Subcutaneous Injection




      • Oral




      • Inhalation






    • MEXICO Outlook (USD Billion, 2019-2035)




    • MEXICO GLP-1 Drug Market by Drug Type




      • Short-acting




      • Long-acting




      • Dual-action






    • MEXICO GLP-1 Drug Market by Distribution Channel Type




      • Hospital Pharmacies




      • Retail Pharmacies




      • Online Pharmacies






    • MEXICO GLP-1 Drug Market by Indication Type




      • Type 2 Diabetes




      • Obesity




      • Cardiovascular Diseases






    • MEXICO GLP-1 Drug Market by Administration Route Type




      • Subcutaneous Injection




      • Oral




      • Inhalation






    • ARGENTINA Outlook (USD Billion, 2019-2035)




    • ARGENTINA GLP-1 Drug Market by Drug Type




      • Short-acting




      • Long-acting




      • Dual-action






    • ARGENTINA GLP-1 Drug Market by Distribution Channel Type




      • Hospital Pharmacies




      • Retail Pharmacies




      • Online Pharmacies






    • ARGENTINA GLP-1 Drug Market by Indication Type




      • Type 2 Diabetes




      • Obesity




      • Cardiovascular Diseases






    • ARGENTINA GLP-1 Drug Market by Administration Route Type




      • Subcutaneous Injection




      • Oral




      • Inhalation






    • REST OF SOUTH AMERICA Outlook (USD Billion, 2019-2035)




    • REST OF SOUTH AMERICA GLP-1 Drug Market by Drug Type




      • Short-acting




      • Long-acting




      • Dual-action






    • REST OF SOUTH AMERICA GLP-1 Drug Market by Distribution Channel Type




      • Hospital Pharmacies




      • Retail Pharmacies




      • Online Pharmacies






    • REST OF SOUTH AMERICA GLP-1 Drug Market by Indication Type




      • Type 2 Diabetes




      • Obesity




      • Cardiovascular Diseases






    • REST OF SOUTH AMERICA GLP-1 Drug Market by Administration Route Type




      • Subcutaneous Injection




      • Oral




      • Inhalation








  • MEA Outlook (USD Billion, 2019-2035)




    • MEA GLP-1 Drug Market by Drug Type




      • Short-acting




      • Long-acting




      • Dual-action






    • MEA GLP-1 Drug Market by Distribution Channel Type




      • Hospital Pharmacies




      • Retail Pharmacies




      • Online Pharmacies






    • MEA GLP-1 Drug Market by Indication Type




      • Type 2 Diabetes




      • Obesity




      • Cardiovascular Diseases






    • MEA GLP-1 Drug Market by Administration Route Type




      • Subcutaneous Injection




      • Oral




      • Inhalation






    • MEA GLP-1 Drug Market by Regional Type




      • GCC Countries




      • South Africa




      • Rest of MEA






    • GCC COUNTRIES Outlook (USD Billion, 2019-2035)




    • GCC COUNTRIES GLP-1 Drug Market by Drug Type




      • Short-acting




      • Long-acting




      • Dual-action






    • GCC COUNTRIES GLP-1 Drug Market by Distribution Channel Type




      • Hospital Pharmacies




      • Retail Pharmacies




      • Online Pharmacies






    • GCC COUNTRIES GLP-1 Drug Market by Indication Type




      • Type 2 Diabetes




      • Obesity




      • Cardiovascular Diseases






    • GCC COUNTRIES GLP-1 Drug Market by Administration Route Type




      • Subcutaneous Injection




      • Oral




      • Inhalation






    • SOUTH AFRICA Outlook (USD Billion, 2019-2035)




    • SOUTH AFRICA GLP-1 Drug Market by Drug Type




      • Short-acting




      • Long-acting




      • Dual-action






    • SOUTH AFRICA GLP-1 Drug Market by Distribution Channel Type




      • Hospital Pharmacies




      • Retail Pharmacies




      • Online Pharmacies






    • SOUTH AFRICA GLP-1 Drug Market by Indication Type




      • Type 2 Diabetes




      • Obesity




      • Cardiovascular Diseases






    • SOUTH AFRICA GLP-1 Drug Market by Administration Route Type




      • Subcutaneous Injection




      • Oral




      • Inhalation






    • REST OF MEA Outlook (USD Billion, 2019-2035)




    • REST OF MEA GLP-1 Drug Market by Drug Type




      • Short-acting




      • Long-acting




      • Dual-action






    • REST OF MEA GLP-1 Drug Market by Distribution Channel Type




      • Hospital Pharmacies




      • Retail Pharmacies




      • Online Pharmacies






    • REST OF MEA GLP-1 Drug Market by Indication Type




      • Type 2 Diabetes




      • Obesity




      • Cardiovascular Diseases






    • REST OF MEA GLP-1 Drug Market by Administration Route Type




      • Subcutaneous Injection




      • Oral




      • Inhalation








 


 

Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Please fill in Business Email for Quick Response

Table of Contents


 


 


 




  1. EXECUTIVE SUMMARY




    1. Market Overview




    2. Key Findings




    3. Market Segmentation




    4. Competitive Landscape




    5. Challenges and Opportunities




    6. Future Outlook






 


 




  1. MARKET INTRODUCTION




    1. Definition




    2. Scope of the study




      1. Research Objective




      2. Assumption




      3. Limitations








  2. RESEARCH METHODOLOGY




    1. Overview




    2. Data Mining




    3. Secondary Research




    4. Primary Research




      1. Primary Interviews and Information Gathering Process




      2. Breakdown of Primary Respondents






    5. Forecasting Model




    6. Market Size Estimation




      1. Bottom-Up Approach




      2. Top-Down Approach






    7. Data Triangulation




    8. Validation






 


 




  1. MARKET DYNAMICS




    1. Overview




    2. Drivers




    3. Restraints




    4. Opportunities






  2. MARKET FACTOR ANALYSIS




    1. Value chain Analysis




    2. Porter's Five Forces Analysis




      1. Bargaining Power of Suppliers




      2. Bargaining Power of Buyers




      3. Threat of New Entrants




      4. Threat of Substitutes




      5. Intensity of Rivalry






    3. COVID-19 Impact Analysis




      1. Market Impact Analysis




      2. Regional Impact




      3. Opportunity and Threat Analysis








 


 




  1. GLP-1 Drug Market, BY Drug Type (USD Billion)




    1. Short-acting




    2. Long-acting




    3. Dual-action






  2. GLP-1 Drug Market, BY Distribution Channel (USD Billion)




    1. Hospital Pharmacies




    2. Retail Pharmacies




    3. Online Pharmacies






  3. GLP-1 Drug Market, BY Indication (USD Billion)




    1. Type 2 Diabetes




    2. Obesity




    3. Cardiovascular Diseases






  4. GLP-1 Drug Market, BY Administration Route (USD Billion)




    1. Subcutaneous Injection




    2. Oral




    3. Inhalation






  5. GLP-1 Drug Market, BY Regional (USD Billion)




    1. North America




      1. US




      2. Canada






    2. Europe




      1. Germany




      2. UK




      3. France




      4. Russia




      5. Italy




      6. Spain




      7. Rest of Europe






    3. APAC




      1. China




      2. India




      3. Japan




      4. South Korea




      5. Malaysia




      6. Thailand




      7. Indonesia




      8. Rest of APAC






    4. South America




      1. Brazil




      2. Mexico




      3. Argentina




      4. Rest of South America






    5. MEA




      1. GCC Countries




      2. South Africa




      3. Rest of MEA








 


 




  1. Competitive Landscape




    1. Overview




    2. Competitive Analysis




    3. Market share Analysis




    4. Major Growth Strategy in the GLP-1 Drug Market




    5. Competitive Benchmarking




    6. Leading Players in Terms of Number of Developments in the GLP-1 Drug Market




    7. Key developments and growth strategies




      1. New Product Launch/Service Deployment




      2. Merger & Acquisitions




      3. Joint Ventures






    8. Major Players Financial Matrix




      1. Sales and Operating Income




      2. Major Players R&D Expenditure. 2023








  2. Company Profiles




    1. Pfizer




      1. Financial Overview




      2. Products Offered




      3. Key Developments




      4. SWOT Analysis




      5. Key Strategies






    2. Sandoz




      1. Financial Overview




      2. Products Offered




      3. Key Developments




      4. SWOT Analysis




      5. Key Strategies






    3. AbbVie




      1. Financial Overview




      2. Products Offered




      3. Key Developments




      4. SWOT Analysis




      5. Key Strategies






    4. Novo Nordisk




      1. Financial Overview




      2. Products Offered




      3. Key Developments




      4. SWOT Analysis




      5. Key Strategies






    5. Eli Lilly




      1. Financial Overview




      2. Products Offered




      3. Key Developments




      4. SWOT Analysis




      5. Key Strategies






    6. Boehringer Ingelheim




      1. Financial Overview




      2. Products Offered




      3. Key Developments




      4. SWOT Analysis




      5. Key Strategies






    7. GSK




      1. Financial Overview




      2. Products Offered




      3. Key Developments




      4. SWOT Analysis




      5. Key Strategies






    8. H.Lundbeck




      1. Financial Overview




      2. Products Offered




      3. Key Developments




      4. SWOT Analysis




      5. Key Strategies






    9. Teva Pharmaceutical Industries




      1. Financial Overview




      2. Products Offered




      3. Key Developments




      4. SWOT Analysis




      5. Key Strategies






    10. BristolMyers Squibb




      1. Financial Overview




      2. Products Offered




      3. Key Developments




      4. SWOT Analysis




      5. Key Strategies






    11. Merck




      1. Financial Overview




      2. Products Offered




      3. Key Developments




      4. SWOT Analysis




      5. Key Strategies






    12. AstraZeneca




      1. Financial Overview




      2. Products Offered




      3. Key Developments




      4. SWOT Analysis




      5. Key Strategies






    13. Amgen




      1. Financial Overview




      2. Products Offered




      3. Key Developments




      4. SWOT Analysis




      5. Key Strategies






    14. Sanofi




      1. Financial Overview




      2. Products Offered




      3. Key Developments




      4. SWOT Analysis




      5. Key Strategies








  3. Appendix




    1. References




    2. Related Reports






LIST Of tables


 




  1. LIST OF ASSUMPTIONS




  2. North America GLP-1 Drug Market SIZE ESTIMATES & FORECAST, BY DRUG TYPE, 2019-2035 (USD Billions)




  3. North America GLP-1 Drug Market SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD Billions)




  4. North America GLP-1 Drug Market SIZE ESTIMATES & FORECAST, BY INDICATION, 2019-2035 (USD Billions)




  5. North America GLP-1 Drug Market SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2035 (USD Billions)




  6. North America GLP-1 Drug Market SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD Billions)




  7. US GLP-1 Drug Market SIZE ESTIMATES & FORECAST, BY DRUG TYPE, 2019-2035 (USD Billions)




  8. US GLP-1 Drug Market SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD Billions)




  9. US GLP-1 Drug Market SIZE ESTIMATES & FORECAST, BY INDICATION, 2019-2035 (USD Billions)




  10. US GLP-1 Drug Market SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2035 (USD Billions)




  11. US GLP-1 Drug Market SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD Billions)




  12. Canada GLP-1 Drug Market SIZE ESTIMATES & FORECAST, BY DRUG TYPE, 2019-2035 (USD Billions)




  13. Canada GLP-1 Drug Market SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD Billions)




  14. Canada GLP-1 Drug Market SIZE ESTIMATES & FORECAST, BY INDICATION, 2019-2035 (USD Billions)




  15. Canada GLP-1 Drug Market SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2035 (USD Billions)




  16. Canada GLP-1 Drug Market SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD Billions)




  17. Europe GLP-1 Drug Market SIZE ESTIMATES & FORECAST, BY DRUG TYPE, 2019-2035 (USD Billions)




  18. Europe GLP-1 Drug Market SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD Billions)




  19. Europe GLP-1 Drug Market SIZE ESTIMATES & FORECAST, BY INDICATION, 2019-2035 (USD Billions)




  20. Europe GLP-1 Drug Market SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2035 (USD Billions)




  21. Europe GLP-1 Drug Market SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD Billions)




  22. Germany GLP-1 Drug Market SIZE ESTIMATES & FORECAST, BY DRUG TYPE, 2019-2035 (USD Billions)




  23. Germany GLP-1 Drug Market SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD Billions)




  24. Germany GLP-1 Drug Market SIZE ESTIMATES & FORECAST, BY INDICATION, 2019-2035 (USD Billions)




  25. Germany GLP-1 Drug Market SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2035 (USD Billions)




  26. Germany GLP-1 Drug Market SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD Billions)




  27. UK GLP-1 Drug Market SIZE ESTIMATES & FORECAST, BY DRUG TYPE, 2019-2035 (USD Billions)




  28. UK GLP-1 Drug Market SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD Billions)




  29. UK GLP-1 Drug Market SIZE ESTIMATES & FORECAST, BY INDICATION, 2019-2035 (USD Billions)




  30. UK GLP-1 Drug Market SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2035 (USD Billions)




  31. UK GLP-1 Drug Market SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD Billions)




  32. France GLP-1 Drug Market SIZE ESTIMATES & FORECAST, BY DRUG TYPE, 2019-2035 (USD Billions)




  33. France GLP-1 Drug Market SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD Billions)




  34. France GLP-1 Drug Market SIZE ESTIMATES & FORECAST, BY INDICATION, 2019-2035 (USD Billions)




  35. France GLP-1 Drug Market SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2035 (USD Billions)




  36. France GLP-1 Drug Market SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD Billions)




  37. Russia GLP-1 Drug Market SIZE ESTIMATES & FORECAST, BY DRUG TYPE, 2019-2035 (USD Billions)




  38. Russia GLP-1 Drug Market SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD Billions)




  39. Russia GLP-1 Drug Market SIZE ESTIMATES & FORECAST, BY INDICATION, 2019-2035 (USD Billions)




  40. Russia GLP-1 Drug Market SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2035 (USD Billions)




  41. Russia GLP-1 Drug Market SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD Billions)




  42. Italy GLP-1 Drug Market SIZE ESTIMATES & FORECAST, BY DRUG TYPE, 2019-2035 (USD Billions)




  43. Italy GLP-1 Drug Market SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD Billions)




  44. Italy GLP-1 Drug Market SIZE ESTIMATES & FORECAST, BY INDICATION, 2019-2035 (USD Billions)




  45. Italy GLP-1 Drug Market SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2035 (USD Billions)




  46. Italy GLP-1 Drug Market SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD Billions)




  47. Spain GLP-1 Drug Market SIZE ESTIMATES & FORECAST, BY DRUG TYPE, 2019-2035 (USD Billions)




  48. Spain GLP-1 Drug Market SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD Billions)




  49. Spain GLP-1 Drug Market SIZE ESTIMATES & FORECAST, BY INDICATION, 2019-2035 (USD Billions)




  50. Spain GLP-1 Drug Market SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2035 (USD Billions)




  51. Spain GLP-1 Drug Market SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD Billions)




  52. Rest of Europe GLP-1 Drug Market SIZE ESTIMATES & FORECAST, BY DRUG TYPE, 2019-2035 (USD Billions)




  53. Rest of Europe GLP-1 Drug Market SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD Billions)




  54. Rest of Europe GLP-1 Drug Market SIZE ESTIMATES & FORECAST, BY INDICATION, 2019-2035 (USD Billions)




  55. Rest of Europe GLP-1 Drug Market SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2035 (USD Billions)




  56. Rest of Europe GLP-1 Drug Market SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD Billions)




  57. APAC GLP-1 Drug Market SIZE ESTIMATES & FORECAST, BY DRUG TYPE, 2019-2035 (USD Billions)




  58. APAC GLP-1 Drug Market SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD Billions)




  59. APAC GLP-1 Drug Market SIZE ESTIMATES & FORECAST, BY INDICATION, 2019-2035 (USD Billions)




  60. APAC GLP-1 Drug Market SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2035 (USD Billions)




  61. APAC GLP-1 Drug Market SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD Billions)




  62. China GLP-1 Drug Market SIZE ESTIMATES & FORECAST, BY DRUG TYPE, 2019-2035 (USD Billions)




  63. China GLP-1 Drug Market SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD Billions)




  64. China GLP-1 Drug Market SIZE ESTIMATES & FORECAST, BY INDICATION, 2019-2035 (USD Billions)




  65. China GLP-1 Drug Market SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2035 (USD Billions)




  66. China GLP-1 Drug Market SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD Billions)




  67. India GLP-1 Drug Market SIZE ESTIMATES & FORECAST, BY DRUG TYPE, 2019-2035 (USD Billions)




  68. India GLP-1 Drug Market SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD Billions)




  69. India GLP-1 Drug Market SIZE ESTIMATES & FORECAST, BY INDICATION, 2019-2035 (USD Billions)




  70. India GLP-1 Drug Market SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2035 (USD Billions)




  71. India GLP-1 Drug Market SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD Billions)




  72. Japan GLP-1 Drug Market SIZE ESTIMATES & FORECAST, BY DRUG TYPE, 2019-2035 (USD Billions)




  73. Japan GLP-1 Drug Market SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD Billions)




  74. Japan GLP-1 Drug Market SIZE ESTIMATES & FORECAST, BY INDICATION, 2019-2035 (USD Billions)




  75. Japan GLP-1 Drug Market SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2035 (USD Billions)




  76. Japan GLP-1 Drug Market SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD Billions)




  77. South Korea GLP-1 Drug Market SIZE ESTIMATES & FORECAST, BY DRUG TYPE, 2019-2035 (USD Billions)




  78. South Korea GLP-1 Drug Market SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD Billions)




  79. South Korea GLP-1 Drug Market SIZE ESTIMATES & FORECAST, BY INDICATION, 2019-2035 (USD Billions)




  80. South Korea GLP-1 Drug Market SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2035 (USD Billions)




  81. South Korea GLP-1 Drug Market SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD Billions)




  82. Malaysia GLP-1 Drug Market SIZE ESTIMATES & FORECAST, BY DRUG TYPE, 2019-2035 (USD Billions)




  83. Malaysia GLP-1 Drug Market SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD Billions)




  84. Malaysia GLP-1 Drug Market SIZE ESTIMATES & FORECAST, BY INDICATION, 2019-2035 (USD Billions)




  85. Malaysia GLP-1 Drug Market SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2035 (USD Billions)




  86. Malaysia GLP-1 Drug Market SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD Billions)




  87. Thailand GLP-1 Drug Market SIZE ESTIMATES & FORECAST, BY DRUG TYPE, 2019-2035 (USD Billions)




  88. Thailand GLP-1 Drug Market SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD Billions)




  89. Thailand GLP-1 Drug Market SIZE ESTIMATES & FORECAST, BY INDICATION, 2019-2035 (USD Billions)




  90. Thailand GLP-1 Drug Market SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2035 (USD Billions)




  91. Thailand GLP-1 Drug Market SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD Billions)




  92. Indonesia GLP-1 Drug Market SIZE ESTIMATES & FORECAST, BY DRUG TYPE, 2019-2035 (USD Billions)




  93. Indonesia GLP-1 Drug Market SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD Billions)




  94. Indonesia GLP-1 Drug Market SIZE ESTIMATES & FORECAST, BY INDICATION, 2019-2035 (USD Billions)




  95. Indonesia GLP-1 Drug Market SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2035 (USD Billions)




  96. Indonesia GLP-1 Drug Market SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD Billions)




  97. Rest of APAC GLP-1 Drug Market SIZE ESTIMATES & FORECAST, BY DRUG TYPE, 2019-2035 (USD Billions)




  98. Rest of APAC GLP-1 Drug Market SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD Billions)




  99. Rest of APAC GLP-1 Drug Market SIZE ESTIMATES & FORECAST, BY INDICATION, 2019-2035 (USD Billions)




  100. Rest of APAC GLP-1 Drug Market SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2035 (USD Billions)




  101. Rest of APAC GLP-1 Drug Market SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD Billions)




  102. South America GLP-1 Drug Market SIZE ESTIMATES & FORECAST, BY DRUG TYPE, 2019-2035 (USD Billions)




  103. South America GLP-1 Drug Market SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD Billions)




  104. South America GLP-1 Drug Market SIZE ESTIMATES & FORECAST, BY INDICATION, 2019-2035 (USD Billions)




  105. South America GLP-1 Drug Market SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2035 (USD Billions)




  106. South America GLP-1 Drug Market SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD Billions)




  107. Brazil GLP-1 Drug Market SIZE ESTIMATES & FORECAST, BY DRUG TYPE, 2019-2035 (USD Billions)




  108. Brazil GLP-1 Drug Market SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD Billions)




  109. Brazil GLP-1 Drug Market SIZE ESTIMATES & FORECAST, BY INDICATION, 2019-2035 (USD Billions)




  110. Brazil GLP-1 Drug Market SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2035 (USD Billions)




  111. Brazil GLP-1 Drug Market SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD Billions)




  112. Mexico GLP-1 Drug Market SIZE ESTIMATES & FORECAST, BY DRUG TYPE, 2019-2035 (USD Billions)




  113. Mexico GLP-1 Drug Market SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD Billions)




  114. Mexico GLP-1 Drug Market SIZE ESTIMATES & FORECAST, BY INDICATION, 2019-2035 (USD Billions)




  115. Mexico GLP-1 Drug Market SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2035 (USD Billions)




  116. Mexico GLP-1 Drug Market SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD Billions)




  117. Argentina GLP-1 Drug Market SIZE ESTIMATES & FORECAST, BY DRUG TYPE, 2019-2035 (USD Billions)




  118. Argentina GLP-1 Drug Market SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD Billions)




  119. Argentina GLP-1 Drug Market SIZE ESTIMATES & FORECAST, BY INDICATION, 2019-2035 (USD Billions)




  120. Argentina GLP-1 Drug Market SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2035 (USD Billions)




  121. Argentina GLP-1 Drug Market SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD Billions)




  122. Rest of South America GLP-1 Drug Market SIZE ESTIMATES & FORECAST, BY DRUG TYPE, 2019-2035 (USD Billions)




  123. Rest of South America GLP-1 Drug Market SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD Billions)




  124. Rest of South America GLP-1 Drug Market SIZE ESTIMATES & FORECAST, BY INDICATION, 2019-2035 (USD Billions)




  125. Rest of South America GLP-1 Drug Market SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2035 (USD Billions)




  126. Rest of South America GLP-1 Drug Market SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD Billions)




  127. MEA GLP-1 Drug Market SIZE ESTIMATES & FORECAST, BY DRUG TYPE, 2019-2035 (USD Billions)




  128. MEA GLP-1 Drug Market SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD Billions)




  129. MEA GLP-1 Drug Market SIZE ESTIMATES & FORECAST, BY INDICATION, 2019-2035 (USD Billions)




  130. MEA GLP-1 Drug Market SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2035 (USD Billions)




  131. MEA GLP-1 Drug Market SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD Billions)




  132. GCC Countries GLP-1 Drug Market SIZE ESTIMATES & FORECAST, BY DRUG TYPE, 2019-2035 (USD Billions)




  133. GCC Countries GLP-1 Drug Market SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD Billions)




  134. GCC Countries GLP-1 Drug Market SIZE ESTIMATES & FORECAST, BY INDICATION, 2019-2035 (USD Billions)




  135. GCC Countries GLP-1 Drug Market SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2035 (USD Billions)




  136. GCC Countries GLP-1 Drug Market SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD Billions)




  137. South Africa GLP-1 Drug Market SIZE ESTIMATES & FORECAST, BY DRUG TYPE, 2019-2035 (USD Billions)




  138. South Africa GLP-1 Drug Market SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD Billions)




  139. South Africa GLP-1 Drug Market SIZE ESTIMATES & FORECAST, BY INDICATION, 2019-2035 (USD Billions)




  140. South Africa GLP-1 Drug Market SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2035 (USD Billions)




  141. South Africa GLP-1 Drug Market SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD Billions)




  142. Rest of MEA GLP-1 Drug Market SIZE ESTIMATES & FORECAST, BY DRUG TYPE, 2019-2035 (USD Billions)




  143. Rest of MEA GLP-1 Drug Market SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD Billions)




  144. Rest of MEA GLP-1 Drug Market SIZE ESTIMATES & FORECAST, BY INDICATION, 2019-2035 (USD Billions)




  145. Rest of MEA GLP-1 Drug Market SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2035 (USD Billions)




  146. Rest of MEA GLP-1 Drug Market SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD Billions)




  147. PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL




  148. ACQUISITION/PARTNERSHIP




 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


LIST Of figures


 




  1. MARKET SYNOPSIS




  2. NORTH AMERICA GLP-1 DRUG MARKET ANALYSIS




  3. US GLP-1 DRUG MARKET ANALYSIS BY DRUG TYPE




  4. US GLP-1 DRUG MARKET ANALYSIS BY DISTRIBUTION CHANNEL




  5. US GLP-1 DRUG MARKET ANALYSIS BY INDICATION




  6. US GLP-1 DRUG MARKET ANALYSIS BY ADMINISTRATION ROUTE




  7. US GLP-1 DRUG MARKET ANALYSIS BY REGIONAL




  8. CANADA GLP-1 DRUG MARKET ANALYSIS BY DRUG TYPE




  9. CANADA GLP-1 DRUG MARKET ANALYSIS BY DISTRIBUTION CHANNEL




  10. CANADA GLP-1 DRUG MARKET ANALYSIS BY INDICATION




  11. CANADA GLP-1 DRUG MARKET ANALYSIS BY ADMINISTRATION ROUTE




  12. CANADA GLP-1 DRUG MARKET ANALYSIS BY REGIONAL




  13. EUROPE GLP-1 DRUG MARKET ANALYSIS




  14. GERMANY GLP-1 DRUG MARKET ANALYSIS BY DRUG TYPE




  15. GERMANY GLP-1 DRUG MARKET ANALYSIS BY DISTRIBUTION CHANNEL




  16. GERMANY GLP-1 DRUG MARKET ANALYSIS BY INDICATION




  17. GERMANY GLP-1 DRUG MARKET ANALYSIS BY ADMINISTRATION ROUTE




  18. GERMANY GLP-1 DRUG MARKET ANALYSIS BY REGIONAL




  19. UK GLP-1 DRUG MARKET ANALYSIS BY DRUG TYPE




  20. UK GLP-1 DRUG MARKET ANALYSIS BY DISTRIBUTION CHANNEL




  21. UK GLP-1 DRUG MARKET ANALYSIS BY INDICATION




  22. UK GLP-1 DRUG MARKET ANALYSIS BY ADMINISTRATION ROUTE




  23. UK GLP-1 DRUG MARKET ANALYSIS BY REGIONAL




  24. FRANCE GLP-1 DRUG MARKET ANALYSIS BY DRUG TYPE




  25. FRANCE GLP-1 DRUG MARKET ANALYSIS BY DISTRIBUTION CHANNEL




  26. FRANCE GLP-1 DRUG MARKET ANALYSIS BY INDICATION




  27. FRANCE GLP-1 DRUG MARKET ANALYSIS BY ADMINISTRATION ROUTE




  28. FRANCE GLP-1 DRUG MARKET ANALYSIS BY REGIONAL




  29. RUSSIA GLP-1 DRUG MARKET ANALYSIS BY DRUG TYPE




  30. RUSSIA GLP-1 DRUG MARKET ANALYSIS BY DISTRIBUTION CHANNEL




  31. RUSSIA GLP-1 DRUG MARKET ANALYSIS BY INDICATION




  32. RUSSIA GLP-1 DRUG MARKET ANALYSIS BY ADMINISTRATION ROUTE




  33. RUSSIA GLP-1 DRUG MARKET ANALYSIS BY REGIONAL




  34. ITALY GLP-1 DRUG MARKET ANALYSIS BY DRUG TYPE




  35. ITALY GLP-1 DRUG MARKET ANALYSIS BY DISTRIBUTION CHANNEL




  36. ITALY GLP-1 DRUG MARKET ANALYSIS BY INDICATION




  37. ITALY GLP-1 DRUG MARKET ANALYSIS BY ADMINISTRATION ROUTE




  38. ITALY GLP-1 DRUG MARKET ANALYSIS BY REGIONAL




  39. SPAIN GLP-1 DRUG MARKET ANALYSIS BY DRUG TYPE




  40. SPAIN GLP-1 DRUG MARKET ANALYSIS BY DISTRIBUTION CHANNEL




  41. SPAIN GLP-1 DRUG MARKET ANALYSIS BY INDICATION




  42. SPAIN GLP-1 DRUG MARKET ANALYSIS BY ADMINISTRATION ROUTE




  43. SPAIN GLP-1 DRUG MARKET ANALYSIS BY REGIONAL




  44. REST OF EUROPE GLP-1 DRUG MARKET ANALYSIS BY DRUG TYPE




  45. REST OF EUROPE GLP-1 DRUG MARKET ANALYSIS BY DISTRIBUTION CHANNEL




  46. REST OF EUROPE GLP-1 DRUG MARKET ANALYSIS BY INDICATION




  47. REST OF EUROPE GLP-1 DRUG MARKET ANALYSIS BY ADMINISTRATION ROUTE




  48. REST OF EUROPE GLP-1 DRUG MARKET ANALYSIS BY REGIONAL




  49. APAC GLP-1 DRUG MARKET ANALYSIS




  50. CHINA GLP-1 DRUG MARKET ANALYSIS BY DRUG TYPE




  51. CHINA GLP-1 DRUG MARKET ANALYSIS BY DISTRIBUTION CHANNEL




  52. CHINA GLP-1 DRUG MARKET ANALYSIS BY INDICATION




  53. CHINA GLP-1 DRUG MARKET ANALYSIS BY ADMINISTRATION ROUTE




  54. CHINA GLP-1 DRUG MARKET ANALYSIS BY REGIONAL




  55. INDIA GLP-1 DRUG MARKET ANALYSIS BY DRUG TYPE




  56. INDIA GLP-1 DRUG MARKET ANALYSIS BY DISTRIBUTION CHANNEL




  57. INDIA GLP-1 DRUG MARKET ANALYSIS BY INDICATION




  58. INDIA GLP-1 DRUG MARKET ANALYSIS BY ADMINISTRATION ROUTE




  59. INDIA GLP-1 DRUG MARKET ANALYSIS BY REGIONAL




  60. JAPAN GLP-1 DRUG MARKET ANALYSIS BY DRUG TYPE




  61. JAPAN GLP-1 DRUG MARKET ANALYSIS BY DISTRIBUTION CHANNEL




  62. JAPAN GLP-1 DRUG MARKET ANALYSIS BY INDICATION




  63. JAPAN GLP-1 DRUG MARKET ANALYSIS BY ADMINISTRATION ROUTE




  64. JAPAN GLP-1 DRUG MARKET ANALYSIS BY REGIONAL




  65. SOUTH KOREA GLP-1 DRUG MARKET ANALYSIS BY DRUG TYPE




  66. SOUTH KOREA GLP-1 DRUG MARKET ANALYSIS BY DISTRIBUTION CHANNEL




  67. SOUTH KOREA GLP-1 DRUG MARKET ANALYSIS BY INDICATION




  68. SOUTH KOREA GLP-1 DRUG MARKET ANALYSIS BY ADMINISTRATION ROUTE




  69. SOUTH KOREA GLP-1 DRUG MARKET ANALYSIS BY REGIONAL




  70. MALAYSIA GLP-1 DRUG MARKET ANALYSIS BY DRUG TYPE




  71. MALAYSIA GLP-1 DRUG MARKET ANALYSIS BY DISTRIBUTION CHANNEL




  72. MALAYSIA GLP-1 DRUG MARKET ANALYSIS BY INDICATION




  73. MALAYSIA GLP-1 DRUG MARKET ANALYSIS BY ADMINISTRATION ROUTE




  74. MALAYSIA GLP-1 DRUG MARKET ANALYSIS BY REGIONAL




  75. THAILAND GLP-1 DRUG MARKET ANALYSIS BY DRUG TYPE




  76. THAILAND GLP-1 DRUG MARKET ANALYSIS BY DISTRIBUTION CHANNEL




  77. THAILAND GLP-1 DRUG MARKET ANALYSIS BY INDICATION




  78. THAILAND GLP-1 DRUG MARKET ANALYSIS BY ADMINISTRATION ROUTE




  79. THAILAND GLP-1 DRUG MARKET ANALYSIS BY REGIONAL




  80. INDONESIA GLP-1 DRUG MARKET ANALYSIS BY DRUG TYPE




  81. INDONESIA GLP-1 DRUG MARKET ANALYSIS BY DISTRIBUTION CHANNEL




  82. INDONESIA GLP-1 DRUG MARKET ANALYSIS BY INDICATION




  83. INDONESIA GLP-1 DRUG MARKET ANALYSIS BY ADMINISTRATION ROUTE




  84. INDONESIA GLP-1 DRUG MARKET ANALYSIS BY REGIONAL




  85. REST OF APAC GLP-1 DRUG MARKET ANALYSIS BY DRUG TYPE




  86. REST OF APAC GLP-1 DRUG MARKET ANALYSIS BY DISTRIBUTION CHANNEL




  87. REST OF APAC GLP-1 DRUG MARKET ANALYSIS BY INDICATION




  88. REST OF APAC GLP-1 DRUG MARKET ANALYSIS BY ADMINISTRATION ROUTE




  89. REST OF APAC GLP-1 DRUG MARKET ANALYSIS BY REGIONAL




  90. SOUTH AMERICA GLP-1 DRUG MARKET ANALYSIS




  91. BRAZIL GLP-1 DRUG MARKET ANALYSIS BY DRUG TYPE




  92. BRAZIL GLP-1 DRUG MARKET ANALYSIS BY DISTRIBUTION CHANNEL




  93. BRAZIL GLP-1 DRUG MARKET ANALYSIS BY INDICATION




  94. BRAZIL GLP-1 DRUG MARKET ANALYSIS BY ADMINISTRATION ROUTE




  95. BRAZIL GLP-1 DRUG MARKET ANALYSIS BY REGIONAL




  96. MEXICO GLP-1 DRUG MARKET ANALYSIS BY DRUG TYPE




  97. MEXICO GLP-1 DRUG MARKET ANALYSIS BY DISTRIBUTION CHANNEL




  98. MEXICO GLP-1 DRUG MARKET ANALYSIS BY INDICATION




  99. MEXICO GLP-1 DRUG MARKET ANALYSIS BY ADMINISTRATION ROUTE




  100. MEXICO GLP-1 DRUG MARKET ANALYSIS BY REGIONAL




  101. ARGENTINA GLP-1 DRUG MARKET ANALYSIS BY DRUG TYPE




  102. ARGENTINA GLP-1 DRUG MARKET ANALYSIS BY DISTRIBUTION CHANNEL




  103. ARGENTINA GLP-1 DRUG MARKET ANALYSIS BY INDICATION




  104. ARGENTINA GLP-1 DRUG MARKET ANALYSIS BY ADMINISTRATION ROUTE




  105. ARGENTINA GLP-1 DRUG MARKET ANALYSIS BY REGIONAL




  106. REST OF SOUTH AMERICA GLP-1 DRUG MARKET ANALYSIS BY DRUG TYPE




  107. REST OF SOUTH AMERICA GLP-1 DRUG MARKET ANALYSIS BY DISTRIBUTION CHANNEL




  108. REST OF SOUTH AMERICA GLP-1 DRUG MARKET ANALYSIS BY INDICATION




  109. REST OF SOUTH AMERICA GLP-1 DRUG MARKET ANALYSIS BY ADMINISTRATION ROUTE




  110. REST OF SOUTH AMERICA GLP-1 DRUG MARKET ANALYSIS BY REGIONAL




  111. MEA GLP-1 DRUG MARKET ANALYSIS




  112. GCC COUNTRIES GLP-1 DRUG MARKET ANALYSIS BY DRUG TYPE




  113. GCC COUNTRIES GLP-1 DRUG MARKET ANALYSIS BY DISTRIBUTION CHANNEL




  114. GCC COUNTRIES GLP-1 DRUG MARKET ANALYSIS BY INDICATION




  115. GCC COUNTRIES GLP-1 DRUG MARKET ANALYSIS BY ADMINISTRATION ROUTE




  116. GCC COUNTRIES GLP-1 DRUG MARKET ANALYSIS BY REGIONAL




  117. SOUTH AFRICA GLP-1 DRUG MARKET ANALYSIS BY DRUG TYPE




  118. SOUTH AFRICA GLP-1 DRUG MARKET ANALYSIS BY DISTRIBUTION CHANNEL




  119. SOUTH AFRICA GLP-1 DRUG MARKET ANALYSIS BY INDICATION




  120. SOUTH AFRICA GLP-1 DRUG MARKET ANALYSIS BY ADMINISTRATION ROUTE




  121. SOUTH AFRICA GLP-1 DRUG MARKET ANALYSIS BY REGIONAL




  122. REST OF MEA GLP-1 DRUG MARKET ANALYSIS BY DRUG TYPE




  123. REST OF MEA GLP-1 DRUG MARKET ANALYSIS BY DISTRIBUTION CHANNEL




  124. REST OF MEA GLP-1 DRUG MARKET ANALYSIS BY INDICATION




  125. REST OF MEA GLP-1 DRUG MARKET ANALYSIS BY ADMINISTRATION ROUTE




  126. REST OF MEA GLP-1 DRUG MARKET ANALYSIS BY REGIONAL




  127. KEY BUYING CRITERIA OF GLP-1 DRUG MARKET




  128. RESEARCH PROCESS OF MRFR




  129. DRO ANALYSIS OF GLP-1 DRUG MARKET




  130. DRIVERS IMPACT ANALYSIS: GLP-1 DRUG MARKET




  131. RESTRAINTS IMPACT ANALYSIS: GLP-1 DRUG MARKET




  132. SUPPLY / VALUE CHAIN: GLP-1 DRUG MARKET




  133. GLP-1 DRUG MARKET, BY DRUG TYPE, 2025 (% SHARE)




  134. GLP-1 DRUG MARKET, BY DRUG TYPE, 2019 TO 2035 (USD Billions)




  135. GLP-1 DRUG MARKET, BY DISTRIBUTION CHANNEL, 2025 (% SHARE)




  136. GLP-1 DRUG MARKET, BY DISTRIBUTION CHANNEL, 2019 TO 2035 (USD Billions)




  137. GLP-1 DRUG MARKET, BY INDICATION, 2025 (% SHARE)




  138. GLP-1 DRUG MARKET, BY INDICATION, 2019 TO 2035 (USD Billions)




  139. GLP-1 DRUG MARKET, BY ADMINISTRATION ROUTE, 2025 (% SHARE)




  140. GLP-1 DRUG MARKET, BY ADMINISTRATION ROUTE, 2019 TO 2035 (USD Billions)




  141. GLP-1 DRUG MARKET, BY REGIONAL, 2025 (% SHARE)




  142. GLP-1 DRUG MARKET, BY REGIONAL, 2019 TO 2035 (USD Billions)




  143. BENCHMARKING OF MAJOR COMPETITORS




 

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
report-img
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.
Related Reports
report-img
Insulin Drugs And Glucagon Like Peptide 1 Receptor Agaonist Market - Forecast till 2035
report-img
Diabetes Drug Market Research Report – Forecast to 2035
report-img
Injectable Anti-Diabetic Drug Market Research Report - Global Forecast by 2035
report-img
Incretin-Based Drug Market Research Report — Global Forecast till 2035
Press Release
Category icon
GLP-1 Drug Market is predicted to reach USD 88.2 billion at a CAGR of 21.00% during the forecast ...
Logo
861332069 Dmca
Paypal new Ssl cf new
Services Syndicate Reports Category Intelligence News How To Order FAQs
Our Company About US Careers Contact Us Terms & Conditions Privacy Policy
Banking Partners Paymentoptions
ISO Certifications
Iso new
✉  info@marketresearchfuture.com
📞  +1 (855) 661-4441(US)
📞  +44 1720 412 167(UK)
📞  +91 2269738890(APAC)

© 2025 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)